tiprankstipranks
Trending News
More News >
CleanSpace Holdings Ltd. (AU:CSX)
:CSX
Australian Market
Advertisement

CleanSpace Holdings Ltd. (CSX) AI Stock Analysis

Compare
6 Followers

Top Page

AU:CSX

CleanSpace Holdings Ltd.

(Sydney:CSX)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 4o)
Rating:47Neutral
Price Target:
AU$0.50
▼(-28.57% Downside)
CleanSpace Holdings Ltd. has a low overall stock score due to significant financial challenges, including negative profitability and weak cash flow performance. The technical analysis suggests a bearish trend with some potential for a short-term rebound, but the valuation remains unattractive due to a negative P/E ratio and no dividend yield. The absence of earnings call data and corporate events further limits positive influences on the score.

CleanSpace Holdings Ltd. (CSX) vs. iShares MSCI Australia ETF (EWA)

CleanSpace Holdings Ltd. Business Overview & Revenue Model

Company DescriptionCleanSpace Holdings Ltd. (CSX) is a company operating within the safety and industrial equipment sector, specializing in the design and manufacture of advanced respiratory protection equipment. The company's core products include powered air purifying respirators (PAPRs) that cater to various industries such as healthcare, industrial, and emergency services. CleanSpace is recognized for its innovative approach to respiratory protection, providing solutions that offer high levels of safety, comfort, and ease of use to its customers.
How the Company Makes MoneyCleanSpace Holdings Ltd. generates revenue primarily through the sale of its respiratory protection equipment, which includes its flagship powered air purifying respirators. The company's revenue model is centered around direct sales to businesses and institutions across various sectors, including healthcare facilities, industrial workplaces, and emergency response units. Additionally, CleanSpace may engage in partnerships or distribution agreements with other companies to expand its market reach and increase sales channels. The company also benefits from ongoing customer relationships, which may lead to repeat sales and the selling of complementary products or accessories, contributing to sustained revenue growth.

CleanSpace Holdings Ltd. Financial Statement Overview

Summary
CleanSpace Holdings Ltd. faces significant financial challenges, with ongoing profitability issues and weak cash flow performance. While revenue growth has shown recent improvement, the company struggles with negative margins and low returns on equity. The balance sheet is moderately leveraged, providing some stability, but overall financial health remains a concern.
Income Statement
45
Neutral
CleanSpace Holdings Ltd. has experienced fluctuating revenue growth, with a recent positive growth rate of 12.25% after a period of decline. However, profitability remains a concern with negative net profit margins and EBIT margins, indicating ongoing operational challenges. The gross profit margin is relatively strong at 74.76%, suggesting effective cost management despite overall losses.
Balance Sheet
55
Neutral
The company's debt-to-equity ratio is moderate at 0.24, indicating a balanced approach to leveraging. However, the return on equity is negative, reflecting the company's struggle to generate profits from shareholders' equity. The equity ratio is not provided, but the overall financial stability is moderate with manageable debt levels.
Cash Flow
40
Negative
Cash flow performance is weak, with a significant decline in free cash flow growth. The operating cash flow to net income ratio is low, indicating challenges in converting income into cash. However, the free cash flow to net income ratio is relatively high, suggesting some efficiency in cash management despite overall cash flow issues.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue19.76M19.76M15.72M12.09M13.36M49.93M
Gross Profit14.78M14.78M11.36M-5.16M9.75M40.27M
EBITDA-824.55K-824.55K-3.49M-10.55M-14.10M17.15M
Net Income-478.28K-478.28K-3.13M-8.13M-11.28M11.39M
Balance Sheet
Total Assets27.57M27.57M26.05M28.98M38.36M50.72M
Cash, Cash Equivalents and Short-Term Investments10.47M10.47M9.76M12.16M24.30M38.24M
Total Debt4.54M4.54M3.45M4.00M4.13M4.38M
Total Liabilities8.41M8.41M6.95M7.02M8.60M9.99M
Stockholders Equity19.16M19.16M19.10M21.96M29.75M40.73M
Cash Flow
Free Cash Flow1.01M1.01M-1.76M-11.97M-13.60M11.73M
Operating Cash Flow1.11M1.11M-1.73M-11.96M-13.00M13.46M
Investing Cash Flow-1.04M-778.38K2.00M7.06M-628.00K-14.18M
Financing Cash Flow-533.88K-559.87K-637.10K-211.49K-357.95K16.19M

CleanSpace Holdings Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.70
Price Trends
50DMA
0.72
Negative
100DMA
0.72
Negative
200DMA
0.58
Positive
Market Momentum
MACD
>-0.01
Negative
RSI
47.75
Neutral
STOCH
30.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CSX, the sentiment is Negative. The current price of 0.7 is below the 20-day moving average (MA) of 0.71, below the 50-day MA of 0.72, and above the 200-day MA of 0.58, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.75 is Neutral, neither overbought nor oversold. The STOCH value of 30.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:CSX.

CleanSpace Holdings Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
52
Neutral
AU$13.43M-1.63-103.74%14.84%39.64%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
48
Neutral
$79.46M-74.00%23.31%-17.35%
47
Neutral
AU$54.87M-2.50%25.72%84.69%
46
Neutral
AU$70.02M-5.38-31.98%34.20%-23.90%
45
Neutral
AU$60.77M-128.19%-14.25%-22.83%
44
Neutral
AU$176.12M-16.52-70.55%-257.32%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:CSX
CleanSpace Holdings Ltd.
0.69
0.32
86.49%
AU:IPD
Impedimed Limited
0.04
-0.02
-32.73%
AU:CYC
Cyclopharm Limited
0.81
-0.57
-41.30%
AU:MX1
Micro-X Ltd.
0.09
0.03
50.00%
AU:EMV
EMvision Medical Devices Ltd.
1.79
-0.09
-4.79%
AU:CBL
Control Bionics Ltd.
0.07
0.01
16.67%

CleanSpace Holdings Ltd. Corporate Events

CleanSpace Holdings Ltd. Releases Corporate Governance Statement for FY2025
Aug 26, 2025

CleanSpace Holdings Ltd. has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, demonstrating transparency and accountability in its operations. This disclosure is crucial for maintaining investor confidence and ensuring compliance with regulatory standards.

The most recent analyst rating on (AU:CSX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.

CleanSpace Holdings Ltd. Releases FY25 Financial Results
Aug 26, 2025

CleanSpace Holdings Ltd. has released its FY25 results presentation, highlighting its financial performance for the year ended June 30, 2025. The presentation provides insights into the company’s financial metrics, including non-IFRS measures like EBITDA and Free Cash Flow, to offer a clearer understanding of its underlying performance. The report emphasizes that past performance is not indicative of future results and advises stakeholders to consider their own financial situations when evaluating the information.

The most recent analyst rating on (AU:CSX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.

CleanSpace Holdings Reports Strong FY25 Results with Positive Growth in Industrial Markets
Aug 26, 2025

CleanSpace Holdings Limited reported strong financial results for FY25, with a 26% increase in revenue to $19.8 million and a gross margin improvement to 75%. The company achieved positive EBITDA and cash flow in the second half of the year, driven by growth in industrial markets, particularly in the USA where revenue increased by 45%. The company’s strategy to expand its presence in industrial markets and launch new products like the ‘CleanSpace WORK’ respirator has shown positive results, with significant growth in Europe and emerging opportunities in Southeast Asia and South America.

The most recent analyst rating on (AU:CSX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.

CleanSpace Holdings Reports Improved Financial Performance for 2025
Aug 26, 2025

CleanSpace Holdings Limited reported a significant improvement in its financial performance for the year ending June 30, 2025. The company’s revenue increased by 25.7% to $19.76 million, while its net loss after tax decreased by 84.7% to $478,276. Despite the improved financial results, no dividends were declared for the period. The company’s earnings per share also showed an improvement, reflecting a more stable financial position. This financial turnaround may positively impact CleanSpace’s market positioning and stakeholder confidence.

The most recent analyst rating on (AU:CSX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.

CleanSpace Holdings to Announce FY25 Financial Results
Jul 30, 2025

CleanSpace Holdings Limited announced it will release its audited financial results for the fiscal year ending June 30, 2025, on August 26, 2025. The announcement will be accompanied by a video and webcast briefing hosted by the company’s leadership. Key dates related to the financial results and shareholder meeting have been outlined, with the annual general meeting scheduled for November 28, 2025. These announcements are crucial for stakeholders as they provide insights into the company’s financial health and strategic direction.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025